BiotechTube
GenoSafe

GenoSafe

Paris, France· Est.
genosafe.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

GenoSafe is a specialized analytical CRO positioned in the high-growth sectors of gene therapy, CRISPR, and synthetic biology. It offers end-to-end analytical support for drug developers, covering preclinical, quality control, and clinical development stages for Advanced Therapy Medicinal Products (ATMPs). The company leverages cutting-edge labs and expert teams to provide flexible, responsive services aligned with evolving regulatory requirements. Its business model is purely service-based, generating revenue by supporting other biotech and pharma companies rather than developing its own therapeutic pipeline.

Gene TherapyCRISPRSynthetic Biology

Technology Platform

Integrated analytical expertise and laboratory infrastructure for the characterization, quality control, and bioanalysis of Advanced Therapy Medicinal Products (ATMPs) including gene/cell therapies and DNA/RNA-based products.

Opportunities

The company is positioned in the high-growth ATMP (Advanced Therapy Medicinal Products) sector, where demand for specialized analytical services is booming due to complex regulatory requirements.
Expansion of service offerings, geographic reach, or forming strategic partnerships with leading therapy developers represent significant growth opportunities.

Risk Factors

Key risks include high dependence on the funding climate for biotech clients, intense competition from larger and niche CROs, and the constant need for capital investment to keep pace with rapid technological evolution in gene and cell therapy analytics.
Execution risk related to regulatory compliance is also paramount.

Competitive Landscape

GenoSafe competes in the specialized analytical CRO space for advanced therapies. Competitors range from large, full-service CROs (e.g., Charles River, LabCorp) to smaller, niche players focusing on cell and gene therapy. Differentiation is based on deep scientific expertise, regulatory acumen, speed, and the quality of client service in a technically demanding field.

More companies in Cell & Gene Therapy →More companies in France →